• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用维替泊芬对小鼠乳腺腺癌细胞系进行体外光致敏。

In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.

作者信息

Casas A, Di Venosa G, Batlle A, Fukuda H

机构信息

Centro de Investigaciones sobre Porfirinas y Porfirias, FCEyN, University of Buenos Aires and CONICET, Ciudad Universitaria, Pabellón II, 2do piso, 1428 Buenos Aires, Argentina.

出版信息

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):931-7.

PMID:12699253
Abstract

Benzoporphyrin derivative monoacid ring A (BPD-MA) is a second generation hydrophobic photosensitiser for PDT that has been approved for ocular disease treatment. In the present paper we report the results of in vitro studies on the photosensitising activity of Verteporfin (liposomally formulated BPD-MA) using an adenocarcinoma derived cell line. Our findings show a quick and efficient uptake of Verteporfin by LM3 cells, reaching maxima concentrations after 5 hr exposure to 18 microg Verteporfin/ml. Independently on the concentration, plateau levels are attained 5 hr after exposure to Verteporfin. Exposure of the cells to the photosensitiser appears to be safe in the darkness within a broad range of concentrations. The hydroxyl radical scavenger mannitol afforded the highest protection against PDT, while L-tryptophan, a well known and efficient singlet oxygen quencher was not an effective protector at all, showing scavenging activity only when it was supplemented at concentration as high as 10 mM and when 50% of the cells were affected, showing that in addition to singlet oxygen, which is considered the primary cytotoxic agent in PDT, other interconvertible reactive oxygen specie (ROS), in particular HO are also generated. Verteporfin-PDT also induced morphological features typical of apoptotic cells. Results of the present work show that the LM3 adenocarcinoma cell can be effectively sensitised with Verteporfin-PDT.

摘要

苯并卟啉衍生物单酸环A(BPD-MA)是第二代用于光动力疗法(PDT)的疏水性光敏剂,已被批准用于眼部疾病治疗。在本文中,我们报告了使用一种腺癌衍生细胞系对维替泊芬(脂质体配方的BPD-MA)的光敏活性进行体外研究的结果。我们的研究结果表明,LM3细胞能快速有效地摄取维替泊芬,在暴露于18微克维替泊芬/毫升5小时后达到最大浓度。无论浓度如何,暴露于维替泊芬5小时后都会达到平台水平。在很宽的浓度范围内,细胞在黑暗中暴露于光敏剂似乎是安全的。羟基自由基清除剂甘露醇对光动力疗法提供了最高的保护作用,而L-色氨酸,一种众所周知且有效的单线态氧猝灭剂,根本不是有效的保护剂,仅在以高达10毫摩尔的浓度添加且50%的细胞受到影响时才显示出清除活性,这表明除了被认为是光动力疗法中主要细胞毒性剂的单线态氧外,其他可相互转化的活性氧物种(ROS),特别是羟基自由基(HO)也会产生。维替泊芬光动力疗法还诱导了凋亡细胞典型的形态特征。本研究结果表明,LM3腺癌细胞可以被维替泊芬光动力疗法有效致敏。

相似文献

1
In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.用维替泊芬对小鼠乳腺腺癌细胞系进行体外光致敏。
Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):931-7.
2
Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.使用苯并卟啉衍生物单酸环 A(BPD-MA)-PDT 体外实验中的显式和隐式剂量指标计算单线态氧剂量,并与 MLL 细胞存活相关联。
Photochem Photobiol. 2011 Sep-Oct;87(5):1129-37. doi: 10.1111/j.1751-1097.2011.00942.x. Epub 2011 Jul 7.
3
Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).在使用光敏剂BPD-MA(维替泊芬)的乳腺癌转移小鼠临床前模型中定义椎体光动力疗法的治疗窗口。
Breast Cancer Res Treat. 2010 Jan;119(2):325-33. doi: 10.1007/s10549-009-0356-7. Epub 2009 Mar 5.
4
Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.使用中-四(4-N-甲基吡啶鎓)卟啉通过重复光动力治疗对小鼠乳腺腺癌LM3进行长期消退。
Int J Oncol. 2005 Oct;27(4):1053-9.
5
Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.在辐射诱导的纤维肉瘤-1肿瘤中使用维替泊芬进行光动力疗法可增强辐射敏感性。
Cancer Res. 2003 Mar 1;63(5):1025-33.
6
Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.用苯并卟啉衍生物的不同类似物抑制接触性超敏反应。
Immunopharmacology. 1997 Oct;37(2-3):221-30. doi: 10.1016/s0162-3109(97)00051-9.
7
Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.维替泊芬、血卟啉衍生物II和部花青540作为抗黑色素瘤细胞的光动力疗法光敏剂。
Biochem Biophys Res Commun. 2006 Oct 20;349(2):549-55. doi: 10.1016/j.bbrc.2006.08.060. Epub 2006 Aug 22.
8
Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.评价单线态氧显式剂量学在预测苯并卟啉衍生物单酸环 A 介导光动力疗法治疗效果中的作用。
J Biomed Opt. 2017 Feb 1;22(2):28002. doi: 10.1117/1.JBO.22.2.028002.
9
Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.在维替泊芬介导的血管靶向治疗中,前列腺肿瘤内部与外周血管系统之间的差异。
Int J Cancer. 2008 Aug 1;123(3):695-701. doi: 10.1002/ijc.23538.
10
Benzoporphyrin derivative monacid ring A (Verteporfin) alone has no inhibitory effect on intimal hyperplasia: in vitro and in vivo results.单酸环A苯并卟啉衍生物(维替泊芬)单独使用对内膜增生无抑制作用:体外和体内实验结果
J Invest Surg. 2000 May-Jun;13(3):153-9. doi: 10.1080/08941930050075847.

引用本文的文献

1
Treatment of canine osseous tumors with photodynamic therapy: a pilot study.光动力疗法治疗犬骨肿瘤:一项初步研究。
Clin Orthop Relat Res. 2009 Apr;467(4):1028-34. doi: 10.1007/s11999-008-0678-5. Epub 2009 Jan 22.